X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2925031/0/en/TFF-Pharmaceuticals-Provides-Continued-Positive-Outcomes-from-Tacrolimus-Inhalation-Powder-TFF-TAC-Phase-2-Trial-for-the-Prevention-of-Lung-Transplant-Rejection.html
https://www.globenewswire.com/news-release/2024/06/26/2904386/0/en/TFF-Pharmaceuticals-Engages-Outcome-Capital-As-a-Strategic-Advisor-for-Evaluating-Partnership-and-Licensing-Opportunities.html
https://www.globenewswire.com/news-release/2024/06/24/2902869/0/en/TFF-Pharmaceuticals-Provides-Regulatory-Update-on-Tacrolimus-Inhalation-Powder-TFF-TAC-Clinical-Program-for-the-Prevention-of-Lung-Transplant-Rejection.html
https://www.globenewswire.com/news-release/2024/05/23/2887154/0/en/TFF-Pharmaceuticals-and-Leidos-to-Advance-Next-Generation-Biodefense-Countermeasures-Under-the-DARPA-PPB-Program-into-Preclinical-Testing.html
https://www.contractpharma.com/contents/view_breaking-news/2024-05-20/tff-pharmaceuticals-cleveland-clinic-to-advance-multiple-influenza-vaccines/?widget=listSection
https://www.globenewswire.com/news-release/2024/05/20/2884752/0/en/TFF-Pharmaceuticals-and-Cleveland-Clinic-to-Advance-Multivalent-Universal-Influenza-Vaccine-Candidates-into-Preclinical-Testing.html
https://www.globenewswire.com/news-release/2024/05/15/2882269/0/en/TFF-Pharmaceuticals-Provides-Update-on-Tacrolimus-Inhalation-Powder-TFF-TAC-Phase-2-Trial-for-the-Prevention-of-Lung-Transplant-Rejection.html
https://www.globenewswire.com/news-release/2024/05/14/2881870/0/en/TFF-Pharmaceuticals-Reports-First-Quarter-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/01/2873726/0/en/TFF-Pharmaceuticals-Announces-Closing-of-Pricing-of-4-8-Million-Public-Offering.html
https://www.globenewswire.com/news-release/2024/04/30/2871744/0/en/TFF-Pharmaceuticals-Announces-Pricing-of-4-8-Million-Public-Offering.html
Market Place
Share 
